InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: TheExpertHimself post# 75738

Tuesday, 05/19/2015 9:13:25 AM

Tuesday, May 19, 2015 9:13:25 AM

Post# of 80868
The company did however seem to be honest this time.

I don't agree with Paulo Santos' view that the company didn't disclose that it had issues with manufacturing. It told us that it was working on optimizing manufacturing, so what was hidden there?

It doesn't need to go down to too much detail as that would be telling competitors too much.

I found that the company was pretty straightforward regarding it's credit and manufacturing, by informing us about the bank's sentiment regarding it's loans and by discussing the transition to Capstone Nutrition....The guidance that the company gave us was based on these material facts, and it was upbeat....meaning that Musclepharm had issues meeting demands that exceeded certain levels in the beginning of Q2, but had no problem growing.